A carregar...
Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update
Macitentan is a medication in the endothelin receptor antagonist class, approved for treatment of pulmonary arterial hypertension in 2013 based on the results of the pivotal SERAPHIN Trial (Study with an Endothelin Receptor Antagonist in Pulmonary arterial Hypertension to Improve cliNical outcome)....
Na minha lista:
| Publicado no: | Drug Healthc Patient Saf |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731963/ https://ncbi.nlm.nih.gov/pubmed/31564989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S173050 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|